The Division of Medical Genetics at Children’s Hospital of Pittsburgh of UPMC is committed to the treatment and study of genetic disorders in children, providing advanced patient care of the highest quality and an active research program dedicated to providing a deeper understanding of the fundamental issues underlying these disorders and developing better therapeutic approaches.

Clinical services, a critical part of the comprehensive care offered by the Division of Medical Genetics, include diagnosis, evaluation, treatment and management of a range of genetic conditions, such as birth defects, chromosomal abnormalities, specific genetic syndromes and inborn errors of metabolism. These services are organized under two programs: an Inborn Errors of Metabolism Clinic and a General Genetics Clinic. Both offer an experienced team of faculty and staff, including physician geneticists, genetic counselors, a nurse practitioner, metabolic dietitian and social worker.

Inborn Errors of Metabolism Clinic
The Inborn Errors of Metabolism Clinic at Children’s Hospital provides diagnostic services, evaluation, treatment management, genetic counseling and other support to children with these inherited disorders and to their families. A Phenylketonuria Clinic specializes in the diagnosis, treatment and management of one of the most common inborn errors of metabolism.

General Genetics Clinic
The General Genetic Clinic provides diagnostic evaluations, appropriate treatment, follow up and support for children with known or suspected genetic disorders that fall outside the scope of the division’s Inborn Errors of Metabolism Clinic.

Counseling, education and other support services to address all of the needs of patients and their families are also provided. Genetic counselors are available to help to identify families at risk, serve as patient advocates, help families understand genetic disorders and their consequences, provide supportive counseling and counsel families who may be at risk for inherited conditions. Division staff members also help families arrange for physical, occupational and speech therapists, comprehensive developmental assessments and other services and support.

Research within the division is providing new insight into genetic disorders from which new and better therapies can be developed. The laboratory research program focuses on discovering the underlying causes of genetic diseases, understanding the clinical implications of mutations in genes, and development of novel approaches for treatment of genetic disorders. An active clinical research program collaborates with other genetic programs world wide to evaluate new therapies for genetic disease.

Referral Requirements

Referrals from primary care physicians, medical and social agencies or other Children’s Hospital specialty services are helpful, but not necessary. Authorization from the patient’s insurance provider and/or primary care physician may be needed for insurance coverage. The Division of Medical Genetics staff can help with these matters. Medical records from previous medical evaluations may be requested. For more information, please call the office number listed.



Clinical Studies

Georgianne Arnold, MD

Read more

Jane Breck, MD, FAAP

Read more

David Finegold, MD

Read more

Katie Long, MS, CGC

Read more

Suneeta Madan, MD

Read more

Gerard Vockley, MD, PhD

Read more

Eric Goetzman, PhD

Read more

Al-Walid Mohsen, PhD

Read more

Yudong Wang, PhD

Read more
  • Genetics

    Children's Hospital of Pittsburgh of UPMC
    4401 Penn Avenue
    Floor 3
    Floor 3 PA, 15224

  • Dietary Treatment for Fat Metabolism Disorders

    Dietary Therapy for Inherited Disorders of Energy Metabolism, Including Mitochondrial Fat Oxidation and Glycogenoses Read more

    Enzyme Deficiency Study

    Laboratory Study of Acyl-CoA Dehydrogenases Read more

    Methylsterol Oxidase Deficiency Study

    Biochemical and Immunologic Characterization of Methylsterol Oxidase Deficiency Read more

    PKU Dietary Management with Lophlex™ Nutritional Drink

    A Study to Monitor Nutritional Status and Metabolic Control and Evaluate Compliance of Patients with Phenylketonuria (PKU) Using Lophlex Low-Volume PKU Drink Read more

    PKU Extended Treatment with rAvPAL-PEG – Phase II

    Long-Term Extension of a Dose-Finding Study to Evaluate the Safety, Efficacy, and Tolerability of Multiple Subcutaneous Doses of rAvPAL-PEG in Subjects with Phenylketonuria (PAL-003) Read more

    Urea Cycle Disorder Treatment with HPN-100 – Phase III

    Open-Label Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (HPN-007) Read more